What’s New in Type 2: The 2021 Diabetes Update (Pharmacist)

What’s New in Type 2: The 2021 Diabetes Update (Pharmacist)

Evidence-based guidelines and recommendations for the prevention, early detection, and treatment of diabetes are critical to optimal health and outcomes for people with diabetes. It is well known that monotherapy cannot achieve glycemic control for many people. When initiating a second-line therapy, clinicians must select among several treatment options and look beyond glycemic lowering. This interactive session will discuss the evidence and best practices of care for people with diabetes, including a review of current American Diabetes Association pharmacotherapy standards of care and the preferred treatment options to improve A1c, cardio-metabolic and renal health, and reduce the risks associated with diabetes.

Upon successful completion of this knowledge-based CPE course, pharmacists should be able to:
1. Summarize recent changes to the American Diabetes Association Management of Hyperglycemia in Type 2 Diabetes.
2. Describe recommendations for appropriately selecting glycemic-lowering medications to reduce ASCVD, HF and/or CKD risk in patients with type 2 diabetes.
3. Discuss contraindications and adverse effect considerations when recommending therapies for people with type 2 diabetes.
4. Formulate patient-centered treatment plans for people with diabetes to reduce cardio-metabolic and renal risk.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Associate Director
Midwestern University College of Pharmacy

Susan Cornell does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Initial Release Date: February 1, 2021
Planned Expiration Date: February 1, 2024

Universal Activity Number (UAN): 0107-0000-21-001-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


1h 0m

Topic Designator

Disease State/Drug Therapy



ACPE Topic

01 Drug Therapy





Release Date






ACPE Number